Literature DB >> 3203525

Properties of the urn randomization in clinical trials.

L J Wei1, J M Lachin.   

Abstract

In this article we review the important statistical properties of the urn randomization (design) for assigning patients to treatment groups in a clinical trial. The urn design is the most widely studied member of the family of adaptive biased-coin designs. Such designs are a compromise between designs that yield perfect balance in treatment assignments and complete randomization which eliminates experimental bias. The urn design forces a small-sized trial to be balanced but approaches complete randomization as the size of the trial (n) increases. Thus, the urn design is not as vulnerable to experimental bias as are other restricted randomization procedures. In a clinical trial it may be difficult to postulate that the study subjects constitute a random sample from a well-defined homogeneous population. In this case, a randomization model provides a preferred basis for statistical inference. We describe the large-sample permutational null distributions of linear rank statistics for testing the equality of treatment groups based on the urn design. In general, these permutation tests may be different from those based on the population model, which is equivalent to assuming complete randomization. Poststratified subgroup analyses can also be performed on the basis of the urn design permutational distribution. This provides a basis for analyzing the subset of patients with observed responses when some patients' responses can be assumed to be missing-at-random. For multiple mutually exclusive strata, these tests are correlated. For this case, a combined covariate-adjusted test of treatment effect is described. Finally, we show how to generalize the urn design to a prospectively stratified trial with a fairly large number of strata.

Entities:  

Mesh:

Year:  1988        PMID: 3203525     DOI: 10.1016/0197-2456(88)90048-7

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  110 in total

1.  A randomized controlled trial of Structural Ecosystems Therapy for HIV medication adherence and substance abuse relapse prevention.

Authors:  Daniel J Feaster; Victoria B Mitrani; Myron J Burns; Brian E McCabe; Ahnalee M Brincks; Allan E Rodriguez; Deshratn Asthana; Michael S Robbins
Journal:  Drug Alcohol Depend       Date:  2010-06-09       Impact factor: 4.492

2.  The effects of interactive and passive distraction on cold pressor pain in preschool-aged children.

Authors:  Karen E Weiss; Lynnda M Dahlquist; Karen Wohlheiter
Journal:  J Pediatr Psychol       Date:  2011-01-29

3.  Combining cognitive behavioral therapy and contingency management to enhance their effects in treating cannabis dependence: less can be more, more or less.

Authors:  Kathleen M Carroll; Charla Nich; Donna M Lapaglia; Erica N Peters; Caroline J Easton; Nancy M Petry
Journal:  Addiction       Date:  2012-05-08       Impact factor: 6.526

4.  Brief strategic family therapy versus treatment as usual: results of a multisite randomized trial for substance using adolescents.

Authors:  Michael S Robbins; Daniel J Feaster; Viviana E Horigian; Michael Rohrbaugh; Varda Shoham; Ken Bachrach; Michael Miller; Kathleen A Burlew; Candy Hodgkins; Ibis Carrion; Nancy Vandermark; Eric Schindler; Robert Werstlein; José Szapocznik
Journal:  J Consult Clin Psychol       Date:  2011-10-03

5.  The efficacy of Structural Ecosystems Therapy for HIV medication adherence with African American women.

Authors:  Daniel J Feaster; Ahnalee M Brincks; Victoria B Mitrani; Guillermo Prado; Seth J Schwartz; Jose Szapocznik
Journal:  J Fam Psychol       Date:  2010-02

6.  Latent structure and factorial invariance of a neuropsychological test battery for the study of preclinical Alzheimer's disease.

Authors:  N Maritza Dowling; Bruce Hermann; Asenath La Rue; Mark A Sager
Journal:  Neuropsychology       Date:  2010-11       Impact factor: 3.295

7.  Gender differences in subjective stress and neuroendocrine response to a stress task among individuals with opioid dependence: A pilot study.

Authors:  Amanda K Gilmore; Constance Guille; Nathaniel L Baker; Kathleen T Brady; Christine K Hahn; Callah M Davis; Jenna L McCauley; Sudie E Back
Journal:  Addict Behav       Date:  2019-01-05       Impact factor: 3.913

8.  Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms.

Authors:  Michael J Mancino; Janette McGaugh; Mohit P Chopra; Joseph B Guise; Christopher Cargile; D Keith Williams; Jeff Thostenson; Thomas R Kosten; Nichole Sanders; Alison Oliveto
Journal:  J Clin Psychopharmacol       Date:  2014-04       Impact factor: 3.153

9.  Design and baseline characteristics of the Food4Me study: a web-based randomised controlled trial of personalised nutrition in seven European countries.

Authors:  Carlos Celis-Morales; Katherine M Livingstone; Cyril F M Marsaux; Hannah Forster; Clare B O'Donovan; Clara Woolhead; Anna L Macready; Rosalind Fallaize; Santiago Navas-Carretero; Rodrigo San-Cristobal; Silvia Kolossa; Kai Hartwig; Lydia Tsirigoti; Christina P Lambrinou; George Moschonis; Magdalena Godlewska; Agnieszka Surwiłło; Keith Grimaldi; Jildau Bouwman; E J Daly; Victor Akujobi; Rick O'Riordan; Jettie Hoonhout; Arjan Claassen; Ulrich Hoeller; Thomas E Gundersen; Siv E Kaland; John N S Matthews; Yannis Manios; Iwona Traczyk; Christian A Drevon; Eileen R Gibney; Lorraine Brennan; Marianne C Walsh; Julie A Lovegrove; J Alfredo Martinez; Wim H M Saris; Hannelore Daniel; Mike Gibney; John C Mathers
Journal:  Genes Nutr       Date:  2014-12-10       Impact factor: 5.523

10.  Neural stress reactivity relates to smoking outcomes and differentiates between mindfulness and cognitive-behavioral treatments.

Authors:  Hedy Kober; Judson A Brewer; Keri L Height; Rajita Sinha
Journal:  Neuroimage       Date:  2016-09-28       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.